Rapid, practical and safe isolation of adipose derived stem cells

References

• Ayala R, Zhang C, Yang D, Hwang Y, Aung A, Shroff SS, Arce FT, Lal R, Arya G, Varghese S. 2011. Engineering the cell–material interface for controlling stem cell adhesion, migration, and differentiation. Biomaterials. 32:3700–3711. doi:10.1016/j.biomaterials.2011.02.004.
   PubMed Web of Science ®Google Scholar
• Baharvand H, Azarnia M, Parivar K, Ashtiani SK. 2005. The effect of extracellular matrix on embryonic stem cell-derived cardiomyocytes. J Mol Cell Cardiol. 38:495–503. doi:10.1016/j.yjmcc.2004.12.011.
   PubMed Web of Science ®Google Scholar
• Benoit DS, Schwartz MP, Durney AR, Anseth KS. 2008. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat Mater. 7:816e23. doi:10.1038/nmat2269.
   Web of Science ®Google Scholar
• Bongso A, Fong C. 2009. Human embryonic stem cells: their nature, properties, and uses. In: Baharvand H, Ed. Trends in stem cell biology and technology. Humana Press; New York. p. 1–18.
   Google Scholar
• Burdick JA, Vunjak-Novakovic G. 2009. Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A. 15:205e19. doi:10.1089/ten.tea.2008.0131.
   Web of Science ®Google Scholar
• Engler AJ, Sen S, Sweeney HL, Discher DE. 2006. Matrix elasticity directs stem cell lineage specification. Cell. 126:677e89. doi:10.1016/j.cell.2006.06.044.
   Web of Science ®Google Scholar
• Frantz C, Stewart KM, Weaver VM. 2010. The extracellular matrix at a glance. J Cell Sci. 123:4195–4200. doi:10.1242/jcs.023820.
   PubMed Web of Science ®Google Scholar
• Ghorbani A, Jalali SA, Varedi M. 2014. Isolation of adipose tissue mesenchymal stem cells without tissue destruction: a non-enzymatic method. Tissue Cell. 46:54–58. doi:10.1016/j.tice.2013.11.002.
   PubMed Web of Science ®Google Scholar
• Gimble J, Guilak F. 2003. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy. 5:362–369. doi:10.1080/14653240310003026.
   PubMed Web of Science ®Google Scholar
• Jarvelainen H, Sainio A, Koulu M, Wight TN, Penttinen R. 2009. Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev. 61:198–223. doi:10.1124/pr.109.001289.
   PubMed Web of Science ®Google Scholar
• Kearns SM, Laywell ED, Kukekov VK, Steindler DA. 2003. Extracellular matrix effects on neurosphere cell motility. Exp Neurol. 182:240–244. doi:10.1016/S0014-4886(03)00124-9.
   PubMed Web of Science ®Google Scholar
• Kobolak J, Dinnyes A, Memice A, Khademhosseini A, Mobasheri A. 2016. Mesenchymal stem cells: identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods. 99:62–68. doi:10.1016/j.ymeth.2015.09.016.
   PubMed Web of Science ®Google Scholar
• Legzdina D, Romanauska A, Nikulshin S, Kozlovska T, Berzins U. 2016. Characterization of senescence of culture-expanded human adipose-derived mesenchymal stem cells. Int J Stem Cells. 9:124–136. doi:10.15283/ijsc.2016.9.1.124.
   PubMed Web of Science ®Google Scholar
• Miguélez-Rivera L, Pérez-Castrillo S, González-Fernández ML, Prieto-Fernández JG, López-González ME, García-Cosamalón J, Villar-Suárez V. 2017. Imunomodulation of mesenchymal stem cells in discogenic pain. Spine J. 18:330–342. doi:10.1016/j.spinee.2017.09.002.
   PubMed Web of Science ®Google Scholar
• Phillips JE, Petrie TA, Creighton FP, Garcia AJ. 2010. Human mesenchymal stem cell differentiation on self-assembled monolayers presenting different surface chemistries. Acta Biomater. 6:12e20. doi:10.1016/j.actbio.2009.07.023.
   Web of Science ®Google Scholar
• Piccini F, Tesei A, Arienti C, Bevilacqua A. 2017. Cell counting and viability assesment of 2D and 3D cell cultures: expected reability of the blue assay. Biol Proc. 19:1–12. doi:10.1186/s12575-017-0056-3.
   PubMedGoogle Scholar
• Prowse AB, Chong F, Gray PP, Munro TP. 2011. Stem cell integrins: implications for ex-vivo culture and cellular therapies. Stem Cell Res. 6:1–12. doi:10.1016/j.scr.2010.09.005.
   PubMed Web of Science ®Google Scholar
• Satija NK, Singh VK, Verma YK, Gupta P, Sharma S, Afrin F, Sharma M, Sharma P, Tripathi RP, Gurudutta GU. 2009. Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med. 13:4385–4402. doi:10.1111/j.1582-4934.2009.00857.x.
   PubMed Web of Science ®Google Scholar
• Trounson A, Thakar RG, Lomax G, Gibbons D. 2011. Clinical trials for stem cell therapies. BMC Med. 9:1–7. doi:10.1186/1741-7015-9-52.
   PubMed Web of Science ®Google Scholar
• Volarevic V, Markovic BS, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N, Armstrong L, Djonov V, Lako M, Stojkovic M. 2018. Ethical and safety issues of stem cell-based therapy. Int J Med Sci. 15:36–45. doi:10.7150/ijms.21666.
   PubMed Web of Science ®Google Scholar
• Yang C, Li J, Lin H, Zhao K, Zheng C, Moser M. 2015. Nasal mucosa derived-mesenchymal stem cells from mice reduce inflammation via modulating immune responses. PLoS One. 10:e0118849. doi:10.1371/journal.pone.0118849.
   PubMed Web of Science ®Google Scholar
• Yu G, Floyd ZE, Wu X. 2011. Isolation of human adipose-derived stem cells from lipoaspirates. Methods Mol Biol. 702:17–27.
   PubMedGoogle Scholar
• Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. 2001. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7:211–228. doi:10.1089/107632701300062859.
   PubMedGoogle Scholar